Inventor

COCHRAN JENNIFER R

US41 patents

⚠️ This page may combine multiple inventors who share the name “COCHRAN JENNIFER R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

COCHRAN JENNIFER R

UNIV LELAND STANFORD JUNIOR

Micro-screening apparatus, process, and products

Conjugated knottin mini-proteins containing non-natural amino acids

Micro-screening apparatus, process, and products

Conjugated knottin mini-proteins containing non-natural amino acids

Fusion proteins comprising an engineered knottin peptide and uses thereof

Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein

Fusion proteins comprising an engineered knottin peptide and uses thereof

Conjugated knottin mini-proteins containing non-natural amino acids

Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis

Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy

Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin

Inhibition of AXL signaling in anti-metastatic therapy

Imaging methods using engineered integrin binding peptides

Knottin-drug conjugates and methods of using the same

Engineered integrin binding peptide compositions

Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin

Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin

Peptides and related compositions and methods

Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy

Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same

Ciliary neurotrophic factor receptor ligands and methods of using the same

Soluble leukemia inhibitory factor receptor polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity

Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen

COCHRAN JENNIFER R

Engineered integrin binding peptides

Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor

Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin

Fusion proteins comprising an engineered knottin peptide and uses thereof

Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of use

Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists

Mutant epidermal growth factor polypeptides with improved biological activity and methods of their making and use

XCELLA BIOSCIENCES INC

Methods and systems for screening using microcapillary arrays

Methods and systems for screening using microcapillary arrays

Methods and systems for screening using microcapillary arrays

Methods and systems for screening using microcapillary arrays

MASSACHUSETTS INST TECHNOLOGY

Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion protein

Methods of treating cancer cells expressing tumor-associated integrins

GIACCIA AMATO J

Inhibition of AXL signaling in anti-metastatic therapy

Inhibition of AXL signaling in anti-metastatic therapy

Nodus Therapeutics

Method of treating cancer with a multiple integrin binding Fc fusion protein

Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulator

HARTMANN LAURA

Surface modification of interpenetrating polymer networks